Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Women with PCOS have more emotional and body image issues than healthy women.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Vesicular carriers like liposomes may improve cosmetic skin treatment delivery and effectiveness but need more human research.

Acne is an important sign of androgen excess disorders in women.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Both genetic and lifestyle factors significantly affect female hair loss.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Finasteride reduces alcohol withdrawal severity and anxiety in mice, but may increase withdrawal severity in some cases.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

The Random Forest algorithm was the most accurate at diagnosing Polycystic Ovarian Syndrome.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

UV-B light increases inflammation-related substances in acne-related skin cells.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Finasteride causes lasting fertility decrease in rats.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.